h357 Search Results


99
CancerTools Org h357
H357, supplied by CancerTools Org, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/h357/product/CancerTools Org
Average 99 stars, based on 1 article reviews
h357 - by Bioz Stars, 2026-03
99/100 stars
  Buy from Supplier

90
European Collection of Authenticated Cell Cultures h357 cell lines
Isolation and identification of tumor stem cells from HNSCC cell lines. (A) Flow cytometry was used to sort ALDH − and ALDH + cells from HNSCC cell lines <t>H357</t> and HSC-3. (B) ALDH + cells suspended in serum-free medium formed cell microspheres (magnification, ×100). (C) Protein expression levels of ALDH in control, ALDH − and ALDH + cells were detected using western blotting, (D) and the results were semiquantified. (E) Western blotting results of the (F) expression levels of tumor stem cell marker genes CD44, Oct-4 and Nanog in ALDH − and ALDH + H357 cells. (G) Western blotting results of the (H) expression levels of tumor stem cell marker genes CD44, Oct-4 and Nanog in ALDH − and ALDH + HSC-3 cells. *P<0.05, **P<0.01, ***P<0.001 vs. Control; ^^ P<0.01, ^^^ P<0.001 vs. ALDH − . ALDH, aldehyde dehydrogenase; HNSCC, head and neck squamous cell carcinoma.
H357 Cell Lines, supplied by European Collection of Authenticated Cell Cultures, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/h357 cell lines/product/European Collection of Authenticated Cell Cultures
Average 90 stars, based on 1 article reviews
h357 cell lines - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

96
tebu-bio sa hilymax
Isolation and identification of tumor stem cells from HNSCC cell lines. (A) Flow cytometry was used to sort ALDH − and ALDH + cells from HNSCC cell lines <t>H357</t> and HSC-3. (B) ALDH + cells suspended in serum-free medium formed cell microspheres (magnification, ×100). (C) Protein expression levels of ALDH in control, ALDH − and ALDH + cells were detected using western blotting, (D) and the results were semiquantified. (E) Western blotting results of the (F) expression levels of tumor stem cell marker genes CD44, Oct-4 and Nanog in ALDH − and ALDH + H357 cells. (G) Western blotting results of the (H) expression levels of tumor stem cell marker genes CD44, Oct-4 and Nanog in ALDH − and ALDH + HSC-3 cells. *P<0.05, **P<0.01, ***P<0.001 vs. Control; ^^ P<0.01, ^^^ P<0.001 vs. ALDH − . ALDH, aldehyde dehydrogenase; HNSCC, head and neck squamous cell carcinoma.
Hilymax, supplied by tebu-bio sa, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/hilymax/product/tebu-bio sa
Average 96 stars, based on 1 article reviews
hilymax - by Bioz Stars, 2026-03
96/100 stars
  Buy from Supplier

Image Search Results


Isolation and identification of tumor stem cells from HNSCC cell lines. (A) Flow cytometry was used to sort ALDH − and ALDH + cells from HNSCC cell lines H357 and HSC-3. (B) ALDH + cells suspended in serum-free medium formed cell microspheres (magnification, ×100). (C) Protein expression levels of ALDH in control, ALDH − and ALDH + cells were detected using western blotting, (D) and the results were semiquantified. (E) Western blotting results of the (F) expression levels of tumor stem cell marker genes CD44, Oct-4 and Nanog in ALDH − and ALDH + H357 cells. (G) Western blotting results of the (H) expression levels of tumor stem cell marker genes CD44, Oct-4 and Nanog in ALDH − and ALDH + HSC-3 cells. *P<0.05, **P<0.01, ***P<0.001 vs. Control; ^^ P<0.01, ^^^ P<0.001 vs. ALDH − . ALDH, aldehyde dehydrogenase; HNSCC, head and neck squamous cell carcinoma.

Journal: Molecular Medicine Reports

Article Title: Silencing the lncRNA NORAD inhibits EMT of head and neck squamous cell carcinoma stem cells via miR-26a-5p

doi: 10.3892/mmr.2021.12383

Figure Lengend Snippet: Isolation and identification of tumor stem cells from HNSCC cell lines. (A) Flow cytometry was used to sort ALDH − and ALDH + cells from HNSCC cell lines H357 and HSC-3. (B) ALDH + cells suspended in serum-free medium formed cell microspheres (magnification, ×100). (C) Protein expression levels of ALDH in control, ALDH − and ALDH + cells were detected using western blotting, (D) and the results were semiquantified. (E) Western blotting results of the (F) expression levels of tumor stem cell marker genes CD44, Oct-4 and Nanog in ALDH − and ALDH + H357 cells. (G) Western blotting results of the (H) expression levels of tumor stem cell marker genes CD44, Oct-4 and Nanog in ALDH − and ALDH + HSC-3 cells. *P<0.05, **P<0.01, ***P<0.001 vs. Control; ^^ P<0.01, ^^^ P<0.001 vs. ALDH − . ALDH, aldehyde dehydrogenase; HNSCC, head and neck squamous cell carcinoma.

Article Snippet: As recommended by the manufacturer, H357 cell lines (cat. no. 06092004) purchased from The European Collection of Authenticated Cell Cultures were cultured in a 37°C, 5% CO 2 environment in DMEM:F12 medium (cat. no. 30-2006) containing 2 mM glutamine (cat. no. 30-2214), 10% FBS (cat. no. 30-2020; all from the American Type Culture Collection), and 0.5 μg/ml sodium hydrocortisone succinate (cat. no. 125-04-2; Pure Chemistry Scientific, Inc.).

Techniques: Isolation, Flow Cytometry, Expressing, Control, Western Blot, Marker

Overexpression and knockdown of NORAD affects the expression levels of stem cell markers in H357 and HSC-3 cell lines. Transfection efficiencies of (A) overexpression and (B) siRNA vector were measured using reverse transcription-quantitative PCR. (C) Western blotting was used to detect the effect of NORAD overexpression on the expression levels of CD44, Oct-4 and Nanog in from H357 ALDH − cells. (D) Relative protein expression levels in H357 ALDH − cells. (E) Western blotting was used to detect the effect of NORAD overexpression on the expression levels of CD44, Oct-4 and Nanog in HSC-3 ALDH − cells. (F) Relative protein expression levels in HSC-3 ALDH − cells. (G) Western blotting was used to detect the effect of NORAD knockdown on the expression levels of CD44, Oct-4 and Nanog in H357 ALDH + cells. (H) Relative protein expression levels in H357 ALDH + cells. (I) Western blotting was used to detect the effect of NORAD knockdown on the expression levels of CD44, Oct-4 and Nanog in HSC-3 ALDH + cells. (J) Relative protein expression levels in HSC-3 ALDH + cells. GAPDH was used as a control. ^^^ P<0.001 vs. NORAD-NC; *P<0.05, **P<0.01, ***P<0.001 vs. siNORAD-siNC. NC, negative control; siRNA, small interfering RNA; NORAD, non-coding RNA activated by DNA damage; ALDH, aldehyde dehydrogenase; lncRNA, long non-coding RNA.

Journal: Molecular Medicine Reports

Article Title: Silencing the lncRNA NORAD inhibits EMT of head and neck squamous cell carcinoma stem cells via miR-26a-5p

doi: 10.3892/mmr.2021.12383

Figure Lengend Snippet: Overexpression and knockdown of NORAD affects the expression levels of stem cell markers in H357 and HSC-3 cell lines. Transfection efficiencies of (A) overexpression and (B) siRNA vector were measured using reverse transcription-quantitative PCR. (C) Western blotting was used to detect the effect of NORAD overexpression on the expression levels of CD44, Oct-4 and Nanog in from H357 ALDH − cells. (D) Relative protein expression levels in H357 ALDH − cells. (E) Western blotting was used to detect the effect of NORAD overexpression on the expression levels of CD44, Oct-4 and Nanog in HSC-3 ALDH − cells. (F) Relative protein expression levels in HSC-3 ALDH − cells. (G) Western blotting was used to detect the effect of NORAD knockdown on the expression levels of CD44, Oct-4 and Nanog in H357 ALDH + cells. (H) Relative protein expression levels in H357 ALDH + cells. (I) Western blotting was used to detect the effect of NORAD knockdown on the expression levels of CD44, Oct-4 and Nanog in HSC-3 ALDH + cells. (J) Relative protein expression levels in HSC-3 ALDH + cells. GAPDH was used as a control. ^^^ P<0.001 vs. NORAD-NC; *P<0.05, **P<0.01, ***P<0.001 vs. siNORAD-siNC. NC, negative control; siRNA, small interfering RNA; NORAD, non-coding RNA activated by DNA damage; ALDH, aldehyde dehydrogenase; lncRNA, long non-coding RNA.

Article Snippet: As recommended by the manufacturer, H357 cell lines (cat. no. 06092004) purchased from The European Collection of Authenticated Cell Cultures were cultured in a 37°C, 5% CO 2 environment in DMEM:F12 medium (cat. no. 30-2006) containing 2 mM glutamine (cat. no. 30-2214), 10% FBS (cat. no. 30-2020; all from the American Type Culture Collection), and 0.5 μg/ml sodium hydrocortisone succinate (cat. no. 125-04-2; Pure Chemistry Scientific, Inc.).

Techniques: Over Expression, Knockdown, Expressing, Transfection, Plasmid Preparation, Reverse Transcription, Real-time Polymerase Chain Reaction, Western Blot, Control, Negative Control, Small Interfering RNA

Long non-coding RNA NORAD knockdown decreases the migration and invasion of tumor stem cells via miR-26a-5p in HNSCC. Wound healing assay results from (A) H357 and (B) HSC-3 cells indicating the migration distances of the Blank, siNORAD-siNC, siNORAD, IC, I and siNORAD+I groups; magnification, ×100. (C) Relative migration rates are presented as bar diagrams. (D) Number of invasive tumor stem cells in each group was determined using Transwell assays in (E) H357 and (F) HSC-3 cells; magnification, ×250). *P<0.05, ***P<0.001 vs. siNORAD-siNC; ^ P<0.05, ^^ P<0.01, ^^^ P<0.001 vs. IC; # P<0.05, ### P<0.001 vs. I; Δ P<0.05, ΔΔΔ P<0.001 vs. siNORAD. I, microRNA-26a-5p inhibitor; IC, inhibitor control; NC, negative control; siRNA, small interfering RNA; NORAD, non-coding RNA activated by DNA damage.

Journal: Molecular Medicine Reports

Article Title: Silencing the lncRNA NORAD inhibits EMT of head and neck squamous cell carcinoma stem cells via miR-26a-5p

doi: 10.3892/mmr.2021.12383

Figure Lengend Snippet: Long non-coding RNA NORAD knockdown decreases the migration and invasion of tumor stem cells via miR-26a-5p in HNSCC. Wound healing assay results from (A) H357 and (B) HSC-3 cells indicating the migration distances of the Blank, siNORAD-siNC, siNORAD, IC, I and siNORAD+I groups; magnification, ×100. (C) Relative migration rates are presented as bar diagrams. (D) Number of invasive tumor stem cells in each group was determined using Transwell assays in (E) H357 and (F) HSC-3 cells; magnification, ×250). *P<0.05, ***P<0.001 vs. siNORAD-siNC; ^ P<0.05, ^^ P<0.01, ^^^ P<0.001 vs. IC; # P<0.05, ### P<0.001 vs. I; Δ P<0.05, ΔΔΔ P<0.001 vs. siNORAD. I, microRNA-26a-5p inhibitor; IC, inhibitor control; NC, negative control; siRNA, small interfering RNA; NORAD, non-coding RNA activated by DNA damage.

Article Snippet: As recommended by the manufacturer, H357 cell lines (cat. no. 06092004) purchased from The European Collection of Authenticated Cell Cultures were cultured in a 37°C, 5% CO 2 environment in DMEM:F12 medium (cat. no. 30-2006) containing 2 mM glutamine (cat. no. 30-2214), 10% FBS (cat. no. 30-2020; all from the American Type Culture Collection), and 0.5 μg/ml sodium hydrocortisone succinate (cat. no. 125-04-2; Pure Chemistry Scientific, Inc.).

Techniques: Knockdown, Migration, Wound Healing Assay, Control, Negative Control, Small Interfering RNA

lncRNA NORAD knockdown attenuates the expression of EMT-related proteins in HNSCC tumor stem cells via miR-26a-5p. (A) Western blot analysis was used to detect the expression of MMP-2, MMP-9, E-cadherin, N-cadherin and Vimentin, and (B) relative protein expression is presented as bar diagrams in H357 cells. Reverse transcription-quantitative PCR was used to determine the mRNA expression of MMP-2, MMP-9, E-cadherin, N-cadherin and Vimentin in (C) H357 and (D) HSC-3 cells. (E) Western blot analysis was used to detect the expression of MMP-2, MMP-9, E-cadherin, N-cadherin and Vimentin, and (F) relative protein expression is presented as bar diagrams in HSC-3 cells. *P<0.05, **P<0.01, ***P<0.001 vs. siNORAD-siNC; ^ P<0.05, ^^ P<0.01, ^^^ P<0.001 vs. IC; # P<0.05, ## P<0.01, ### P<0.001 vs. I; Δ P<0.05, ΔΔ P<0.01, ΔΔΔ P<0.001 vs. siNORAD. I, microRNA-26a-5p inhibitor; IC, inhibitor control; NC, negative control; siRNA, small interfering RNA; NORAD, non-coding RNA activated by DNA damage.

Journal: Molecular Medicine Reports

Article Title: Silencing the lncRNA NORAD inhibits EMT of head and neck squamous cell carcinoma stem cells via miR-26a-5p

doi: 10.3892/mmr.2021.12383

Figure Lengend Snippet: lncRNA NORAD knockdown attenuates the expression of EMT-related proteins in HNSCC tumor stem cells via miR-26a-5p. (A) Western blot analysis was used to detect the expression of MMP-2, MMP-9, E-cadherin, N-cadherin and Vimentin, and (B) relative protein expression is presented as bar diagrams in H357 cells. Reverse transcription-quantitative PCR was used to determine the mRNA expression of MMP-2, MMP-9, E-cadherin, N-cadherin and Vimentin in (C) H357 and (D) HSC-3 cells. (E) Western blot analysis was used to detect the expression of MMP-2, MMP-9, E-cadherin, N-cadherin and Vimentin, and (F) relative protein expression is presented as bar diagrams in HSC-3 cells. *P<0.05, **P<0.01, ***P<0.001 vs. siNORAD-siNC; ^ P<0.05, ^^ P<0.01, ^^^ P<0.001 vs. IC; # P<0.05, ## P<0.01, ### P<0.001 vs. I; Δ P<0.05, ΔΔ P<0.01, ΔΔΔ P<0.001 vs. siNORAD. I, microRNA-26a-5p inhibitor; IC, inhibitor control; NC, negative control; siRNA, small interfering RNA; NORAD, non-coding RNA activated by DNA damage.

Article Snippet: As recommended by the manufacturer, H357 cell lines (cat. no. 06092004) purchased from The European Collection of Authenticated Cell Cultures were cultured in a 37°C, 5% CO 2 environment in DMEM:F12 medium (cat. no. 30-2006) containing 2 mM glutamine (cat. no. 30-2214), 10% FBS (cat. no. 30-2020; all from the American Type Culture Collection), and 0.5 μg/ml sodium hydrocortisone succinate (cat. no. 125-04-2; Pure Chemistry Scientific, Inc.).

Techniques: Knockdown, Expressing, Western Blot, Reverse Transcription, Real-time Polymerase Chain Reaction, Control, Negative Control, Small Interfering RNA